Literature DB >> 25820896

Cortical strut bone grafting and long-stem endoprosthetic reconstruction following massive bone tumour resection in the lower limb.

H Qu1, W Guo1, R Yang1, X Tang1, T Yan1, D Li1, Y Yang1, J Zang1.   

Abstract

We determined the efficacy of a devitalised autograft (n = 13) and allograft (n = 16) cortical strut bone graft combined with long-stem endoprosthetic reconstruction in the treatment of massive tumours of the lower limb. A total of 29 patients (18 men:11 women, mean age 20.1 years (12 to 45) with a ratio of length of resection to that of the whole prosthesis of > 50% were treated between May 2003 and May 2012. The mean follow-up was 47 months (15 to 132). The stem of the prosthesis was introduced through bone graft struts filled with cement, then cemented into the residual bone. Bone healing was achieved in 23 patients (86%). The mean Musculoskeletal Tumour Society functional score was 85% (57 to 97). The five-year survival rate of the endoprostheses was 81% (95% confidence intervals 67.3 to 92.3). The mean length of devitalised autografts and allografts was 8.6 cm (5 to 15), which increased the ratio of the the length of the stem of the prosthesis to that of the whole length of the prosthesis from a theoretical 35% to an actual 55%. Cortical strut bone grafting and long-stem endoprosthetic reconstruction is an option for treating massive segmental defects following resection of a tumour in the lower limb. Patients can regain good function with a low incidence of aseptic loosening. The strut graft and the residual bone together serve as a satisfactory bony environment for a revision prosthesis, if required, once union is achieved. ©2015 The British Editorial Society of Bone & Joint Surgery.

Entities:  

Keywords:  Massive bone tumour; Long-stem endoprosthesis; Bone strut grafting; Reconstruction

Mesh:

Year:  2015        PMID: 25820896     DOI: 10.1302/0301-620X.97B4.34695

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  6 in total

1.  Long-term functional and radiological outcomes of allograft hip prosthesis composite. A fourteen -year follow-up study.

Authors:  Arnaud Dubory; Eric Mascard; Méryl Dahan; Philippe Anract; Charles Court; Stéphane Boisgard; Brice Viard; Gilles Missenard
Journal:  Int Orthop       Date:  2016-12-03       Impact factor: 3.075

2.  Strut Onlay Allograft in Revision Arthroplasty: Osseous Union and Clinical Outcome.

Authors:  Dietmar Dammerer; Alexander Wurm; Clemens Frischhut; Johannes Petersen; Miar Ouaret; Michael Liebensteiner
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

3.  Interlocking reconstruction-mode stem-sideplates preserve at-risk hips with short residual proximal femora.

Authors:  Alexander B Christ; Tomohiro Fujiwara; Mohamed A Yakoub; John H Healey
Journal:  Bone Joint J       Date:  2021-02       Impact factor: 5.082

4.  Development of a Three-Dimensional (3D) Printed Biodegradable Cage to Convert Morselized Corticocancellous Bone Chips into a Structured Cortical Bone Graft.

Authors:  Ying-Chao Chou; Demei Lee; Tzu-Min Chang; Yung-Heng Hsu; Yi-Hsun Yu; Shih-Jung Liu; Steve Wen-Neng Ueng
Journal:  Int J Mol Sci       Date:  2016-04-20       Impact factor: 5.923

Review 5.  Advances in tumour endoprostheses: a systematic review.

Authors:  Maria A Smolle; Dimosthenis Andreou; Per-Ulf Tunn; Andreas Leithner
Journal:  EFORT Open Rev       Date:  2019-07-02

6.  Hip-Preserved Reconstruction Using a Customized Cementless Intercalary Endoprosthesis With an Intra-Neck Curved Stem in Patients With an Ultrashort Proximal Femur: Midterm Follow-Up Outcomes.

Authors:  Qi You; Minxun Lu; Li Min; Yuqi Zhang; Jie Wang; Yitian Wang; Chuanxi Zheng; Yong Zhou; Chongqi Tu
Journal:  Front Bioeng Biotechnol       Date:  2022-02-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.